The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care.
Venture capitallongitudecapital.comSince 2025-10-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Veradermics Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-10-16 | [ PART ] |
No sector on record.